Vicore Pharma Holding AB (publ) (VICO) — Cash Flow Reinvestment Rate
Latest as of March 2024:
3.03x
Vicore Pharma Holding AB (publ) (VICO) has a Cash Flow Reinvestment Rate of 3.03x as of March 2024, reinvesting Skr70.00 Million (capex Skr0.00 plus investments Skr70.00 Million) from operating cash flow of Skr23.08 Million. Check cash flow quality index of Vicore Pharma Holding AB (publ) to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
3.03x
(Capex + Investments) / Operating CF
Total Reinvested
Skr70.00 Million
Capex + Investments
Operating Cash Flow
Skr23.08 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Vicore Pharma Holding AB (publ) (None–None)
Year-by-year capital reinvestment analysis for Vicore Pharma Holding AB (publ). For live market cap and broader valuation context, see Vicore Pharma Holding AB (publ) (VICO) total market value.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow